Multiple myeloma is a heterogeneous disease. Its chromosomal abnormalities have been extensively studied with a view to accurate prognostication and personalized therapy. Here, we describe the techniques commonly employed for elucidating chromosomal aberrations, prognostic impact of recurrent chromosomal abnormalities, and recently updated risk stratification systems.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-4939-6703-2_23 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!